FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017693101> ?p ?o ?g. }

• W2017693101 endingPage "52" @default.
• W2017693101 startingPage "48" @default.
• W2017693101 abstract "Abstract Background and aims NXN-188 is a combined neuronal nitric oxide synthase (nNOS) inhibitor and 5HT-1B/1D receptor agonist which has previously shown efficacy in the acute treatment of migraine. Nitric oxide (NO) is involved in the pathogenesis of migraine pain and is formed after cortical spreading depression. Therefore NXN-188 could perhaps prevent the development of the headache phase in migraine with aura if taken during the aura. The aims of the present study were to evaluate the efficacy and safety of 600mg NXN-188 in the acute treatment of migraine when dosed during the aura. Methods A single-centre, randomized, double-blind, placebo-controlled, two-way crossover trial. The study medication was taken during the aura and the patients kept a study diary for 48h post-dose. Results Of 615 patients screened, 50 patients were included in the study and randomized. Only 18 patients completed both treatments in compliance with the study procedures. 22% of patients reported freedom of headache at 2h after intake of NXN-188 compared with only 11% of patients after placebo. Conclusions The dual-action drug NXN-188 with 5HT-1B/1D agonism and nNOS inhibition, taken orally during the aura phase did not have a statistically substantial effect on migraine headache in this study. This study was limited by a high drop-out rate and small sample of included patients who were able to complete the cross-over protocol. Therefore, efficacy of the treatment cannot be refuted with certainty. Implications This study illustrates the difficulties of doing well controlled studies in migraine patients with aura. nNOS inhibition is expected to be effective mostly in the aura phase, i.e. the oral administration may have had too slow pharmacokinetics to have effect. Parenteral administration may overcome this obstacle. 5HT-1B/1D agonism is not effective when dosed during migraine aura. Repeated dosing of the NXN-188 during and immediately following the aura may have exploited more the dualaction. The high drop-out rate may be reduced in future studies by having the patients familiarize themselves with the study procedure by filling out the attack report form while treating one attack with their own medication before entering the trial. A parallel group comparison may be a more effective trial design for treatment during an aura." @default.
• W2017693101 created "2016-06-24" @default.
• W2017693101 creator A5015767853 @default.
• W2017693101 creator A5036844498 @default.
• W2017693101 creator A5038961547 @default.
• W2017693101 creator A5050108933 @default.
• W2017693101 date "2013-01-01" @default.
• W2017693101 modified "2023-10-18" @default.
• W2017693101 title "The nitric oxide synthase inhibitor and serotonin-receptor agonist NXN-188 during the aura phase of migraine with aura: A randomized, double-blind, placebo-controlled cross-over study" @default.
• W2017693101 cites W1970860218 @default.
• W2017693101 cites W1991706043 @default.
• W2017693101 cites W2006079819 @default.
• W2017693101 cites W2011852384 @default.
• W2017693101 cites W2012191233 @default.
• W2017693101 cites W2040792219 @default.
• W2017693101 cites W2054759302 @default.
• W2017693101 cites W2059514138 @default.
• W2017693101 cites W2073942073 @default.
• W2017693101 cites W2083330259 @default.
• W2017693101 cites W2090146614 @default.
• W2017693101 cites W2094826531 @default.
• W2017693101 cites W2121070581 @default.
• W2017693101 cites W2140565441 @default.
• W2017693101 cites W2157324196 @default.
• W2017693101 cites W2169315230 @default.
• W2017693101 doi "https://doi.org/10.1016/j.sjpain.2012.08.002" @default.
• W2017693101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29913885" @default.
• W2017693101 hasPublicationYear "2013" @default.
• W2017693101 type Work @default.
• W2017693101 sameAs 2017693101 @default.
• W2017693101 citedByCount "23" @default.
• W2017693101 countsByYear W20176931012013 @default.
• W2017693101 countsByYear W20176931012014 @default.
• W2017693101 countsByYear W20176931012015 @default.
• W2017693101 countsByYear W20176931012016 @default.
• W2017693101 countsByYear W20176931012017 @default.
• W2017693101 countsByYear W20176931012018 @default.
• W2017693101 countsByYear W20176931012019 @default.
• W2017693101 countsByYear W20176931012020 @default.
• W2017693101 countsByYear W20176931012021 @default.
• W2017693101 countsByYear W20176931012023 @default.
• W2017693101 crossrefType "journal-article" @default.
• W2017693101 hasAuthorship W2017693101A5015767853 @default.
• W2017693101 hasAuthorship W2017693101A5036844498 @default.
• W2017693101 hasAuthorship W2017693101A5038961547 @default.
• W2017693101 hasAuthorship W2017693101A5050108933 @default.
• W2017693101 hasConcept C126322002 @default.
• W2017693101 hasConcept C142724271 @default.
• W2017693101 hasConcept C168563851 @default.
• W2017693101 hasConcept C170493617 @default.
• W2017693101 hasConcept C204787440 @default.
• W2017693101 hasConcept C27081682 @default.
• W2017693101 hasConcept C2776497919 @default.
• W2017693101 hasConcept C2777350023 @default.
• W2017693101 hasConcept C2778541695 @default.
• W2017693101 hasConcept C2778938600 @default.
• W2017693101 hasConcept C2909221823 @default.
• W2017693101 hasConcept C42219234 @default.
• W2017693101 hasConcept C71924100 @default.
• W2017693101 hasConcept C87813604 @default.
• W2017693101 hasConcept C90924648 @default.
• W2017693101 hasConcept C98274493 @default.
• W2017693101 hasConceptScore W2017693101C126322002 @default.
• W2017693101 hasConceptScore W2017693101C142724271 @default.
• W2017693101 hasConceptScore W2017693101C168563851 @default.
• W2017693101 hasConceptScore W2017693101C170493617 @default.
• W2017693101 hasConceptScore W2017693101C204787440 @default.
• W2017693101 hasConceptScore W2017693101C27081682 @default.
• W2017693101 hasConceptScore W2017693101C2776497919 @default.
• W2017693101 hasConceptScore W2017693101C2777350023 @default.
• W2017693101 hasConceptScore W2017693101C2778541695 @default.
• W2017693101 hasConceptScore W2017693101C2778938600 @default.
• W2017693101 hasConceptScore W2017693101C2909221823 @default.
• W2017693101 hasConceptScore W2017693101C42219234 @default.
• W2017693101 hasConceptScore W2017693101C71924100 @default.
• W2017693101 hasConceptScore W2017693101C87813604 @default.
• W2017693101 hasConceptScore W2017693101C90924648 @default.
• W2017693101 hasConceptScore W2017693101C98274493 @default.
• W2017693101 hasIssue "1" @default.
• W2017693101 hasLocation W20176931011 @default.
• W2017693101 hasLocation W20176931012 @default.
• W2017693101 hasOpenAccess W2017693101 @default.
• W2017693101 hasPrimaryLocation W20176931011 @default.
• W2017693101 hasRelatedWork W1966827407 @default.
• W2017693101 hasRelatedWork W1974501762 @default.
• W2017693101 hasRelatedWork W1989505850 @default.
• W2017693101 hasRelatedWork W2068370202 @default.
• W2017693101 hasRelatedWork W2071531614 @default.
• W2017693101 hasRelatedWork W2083330259 @default.
• W2017693101 hasRelatedWork W2112879785 @default.
• W2017693101 hasRelatedWork W2123978981 @default.
• W2017693101 hasRelatedWork W2584538974 @default.
• W2017693101 hasRelatedWork W4286433207 @default.
• W2017693101 hasVolume "4" @default.
• W2017693101 isParatext "false" @default.
• W2017693101 isRetracted "false" @default.
• W2017693101 magId "2017693101" @default.
• W2017693101 workType "article" @default.